Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

Maja Puchades, Sara Folkesson Hansson, Carol L. Nilsson, Niels Andreasen, Kaj Blennow, Pia Davidsson

Research output: Contribution to journalArticle

241 Citations (Scopus)

Abstract

By comparing the cerebrospinal fluid (CSF) proteome between Alzheimer's disease (AD) patients and controls, it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD. Two-dimensional gel electrophoresis (2-DE), SYPRO Ruby staining and mass spectrometry were used for clinical screening of disease-influenced CSF proteins in AD patients compared to controls. In order to increase the detection of CSF proteins and to improve the separation of protein isoforms in a 2-D gel, micro-narrow range IPG strips were used. The levels of eight proteins and their isoforms, including apolipoprotein A1, apolipoprotein E, apolipoprotein J, β-trace, retinol-binding protein, kininogen, α-1 antitrypsin, cell cycle progression 8 protein, and α-1β glycoprotein were significantly altered in CSF of AD patients compared to controls. Furthermore, we also used liquid-phase IEF, as a prefractionation step, prior to 2-DE for comparison of CSF proteins between individual AD patients and controls. The levels of 37 proteins spots were altered in AD patients. One of the identified proteins, α-2-HS glycoprotein, has not previously been linked to AD. Our study shows that several glycoproteins are altered in AD.

Original languageEnglish
Pages (from-to)140-146
Number of pages7
JournalMolecular Brain Research
Volume118
Issue number1-2
DOIs
StatePublished - Oct 21 2003
Externally publishedYes

Fingerprint

Cerebrospinal Fluid Proteins
Proteomics
Alzheimer Disease
Glycoproteins
Cerebrospinal Fluid
Protein Isoforms
Proteins
Cellular Retinol-Binding Proteins
Clusterin
Kininogens
Apolipoprotein A-I
Electrophoresis, Gel, Two-Dimensional
Apolipoproteins E
Proteome
Mass Spectrometry
Cell Cycle
Gels
Staining and Labeling

Keywords

  • 2-DE
  • Alzheimer's disease
  • Cerebrospinal fluid
  • Liquid-phase IEF
  • Mass spectrometry
  • Proteomics

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N., Blennow, K., & Davidsson, P. (2003). Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Molecular Brain Research, 118(1-2), 140-146. https://doi.org/10.1016/j.molbrainres.2003.08.005

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. / Puchades, Maja; Hansson, Sara Folkesson; Nilsson, Carol L.; Andreasen, Niels; Blennow, Kaj; Davidsson, Pia.

In: Molecular Brain Research, Vol. 118, No. 1-2, 21.10.2003, p. 140-146.

Research output: Contribution to journalArticle

Puchades, M, Hansson, SF, Nilsson, CL, Andreasen, N, Blennow, K & Davidsson, P 2003, 'Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease', Molecular Brain Research, vol. 118, no. 1-2, pp. 140-146. https://doi.org/10.1016/j.molbrainres.2003.08.005
Puchades, Maja ; Hansson, Sara Folkesson ; Nilsson, Carol L. ; Andreasen, Niels ; Blennow, Kaj ; Davidsson, Pia. / Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. In: Molecular Brain Research. 2003 ; Vol. 118, No. 1-2. pp. 140-146.
@article{e30c94f69fdb4dbcb6db86c6917b70c0,
title = "Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease",
abstract = "By comparing the cerebrospinal fluid (CSF) proteome between Alzheimer's disease (AD) patients and controls, it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD. Two-dimensional gel electrophoresis (2-DE), SYPRO Ruby staining and mass spectrometry were used for clinical screening of disease-influenced CSF proteins in AD patients compared to controls. In order to increase the detection of CSF proteins and to improve the separation of protein isoforms in a 2-D gel, micro-narrow range IPG strips were used. The levels of eight proteins and their isoforms, including apolipoprotein A1, apolipoprotein E, apolipoprotein J, β-trace, retinol-binding protein, kininogen, α-1 antitrypsin, cell cycle progression 8 protein, and α-1β glycoprotein were significantly altered in CSF of AD patients compared to controls. Furthermore, we also used liquid-phase IEF, as a prefractionation step, prior to 2-DE for comparison of CSF proteins between individual AD patients and controls. The levels of 37 proteins spots were altered in AD patients. One of the identified proteins, α-2-HS glycoprotein, has not previously been linked to AD. Our study shows that several glycoproteins are altered in AD.",
keywords = "2-DE, Alzheimer's disease, Cerebrospinal fluid, Liquid-phase IEF, Mass spectrometry, Proteomics",
author = "Maja Puchades and Hansson, {Sara Folkesson} and Nilsson, {Carol L.} and Niels Andreasen and Kaj Blennow and Pia Davidsson",
year = "2003",
month = "10",
day = "21",
doi = "10.1016/j.molbrainres.2003.08.005",
language = "English",
volume = "118",
pages = "140--146",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

AU - Puchades, Maja

AU - Hansson, Sara Folkesson

AU - Nilsson, Carol L.

AU - Andreasen, Niels

AU - Blennow, Kaj

AU - Davidsson, Pia

PY - 2003/10/21

Y1 - 2003/10/21

N2 - By comparing the cerebrospinal fluid (CSF) proteome between Alzheimer's disease (AD) patients and controls, it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD. Two-dimensional gel electrophoresis (2-DE), SYPRO Ruby staining and mass spectrometry were used for clinical screening of disease-influenced CSF proteins in AD patients compared to controls. In order to increase the detection of CSF proteins and to improve the separation of protein isoforms in a 2-D gel, micro-narrow range IPG strips were used. The levels of eight proteins and their isoforms, including apolipoprotein A1, apolipoprotein E, apolipoprotein J, β-trace, retinol-binding protein, kininogen, α-1 antitrypsin, cell cycle progression 8 protein, and α-1β glycoprotein were significantly altered in CSF of AD patients compared to controls. Furthermore, we also used liquid-phase IEF, as a prefractionation step, prior to 2-DE for comparison of CSF proteins between individual AD patients and controls. The levels of 37 proteins spots were altered in AD patients. One of the identified proteins, α-2-HS glycoprotein, has not previously been linked to AD. Our study shows that several glycoproteins are altered in AD.

AB - By comparing the cerebrospinal fluid (CSF) proteome between Alzheimer's disease (AD) patients and controls, it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD. Two-dimensional gel electrophoresis (2-DE), SYPRO Ruby staining and mass spectrometry were used for clinical screening of disease-influenced CSF proteins in AD patients compared to controls. In order to increase the detection of CSF proteins and to improve the separation of protein isoforms in a 2-D gel, micro-narrow range IPG strips were used. The levels of eight proteins and their isoforms, including apolipoprotein A1, apolipoprotein E, apolipoprotein J, β-trace, retinol-binding protein, kininogen, α-1 antitrypsin, cell cycle progression 8 protein, and α-1β glycoprotein were significantly altered in CSF of AD patients compared to controls. Furthermore, we also used liquid-phase IEF, as a prefractionation step, prior to 2-DE for comparison of CSF proteins between individual AD patients and controls. The levels of 37 proteins spots were altered in AD patients. One of the identified proteins, α-2-HS glycoprotein, has not previously been linked to AD. Our study shows that several glycoproteins are altered in AD.

KW - 2-DE

KW - Alzheimer's disease

KW - Cerebrospinal fluid

KW - Liquid-phase IEF

KW - Mass spectrometry

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=0141957321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141957321&partnerID=8YFLogxK

U2 - 10.1016/j.molbrainres.2003.08.005

DO - 10.1016/j.molbrainres.2003.08.005

M3 - Article

VL - 118

SP - 140

EP - 146

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -